Zeplatt-SP Tablet is a combination analgesic and anti-inflammatory medication containing Aceclofenac 100 mg, Paracetamol 325 mg, and Serratiopeptidase 10 mg. Aceclofenac, a non-steroidal anti-inflammatory drug (NSAID), provides effective relief from pain and inflammation by inhibiting cyclooxygenase enzymes, thereby reducing prostaglandin synthesis. Paracetamol acts as an analgesic and antipyretic, offering symptomatic relief from mild to moderate pain and fever through central inhibition of prostaglandin synthesis. Serratiopeptidase, a proteolytic enzyme, facilitates the breakdown of inflammatory mediators and promotes the resolution of edema and inflammation, enhancing tissue repair. This combination is indicated for the management of musculoskeletal disorders such as osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, and soft tissue injuries including sprains, strains, and post-operative inflammation. Zeplatt-SP Tablet provides synergistic pain relief while minimizing inflammation and swelling, improving patient comfort and mobility. It should be used under medical supervision, with caution in patients with gastrointestinal ulcers, hepatic or renal impairment, and hypersensitivity to any component. Common side effects may include gastrointestinal discomfort, nausea, or allergic reactions. Regular monitoring is advised during prolonged therapy to ensure safety and efficacy.